Leon Chen

Leon Chen

Director/Board Member at
Remix Therapeutics, Inc.
51 year
Health Technology
Finance
Consumer Services

Profile

Dr. Leon E.
Chen
is a Partner at The Column Group LLC.
He is on the Board of Directors at Remix Therapeutics, Inc. Dr. Chen was previously employed as an Independent Director by Nurix Therapeutics, Inc., an Independent Director by LogicBio Therapeutics, Inc., a Venture Partner by OrbiMed Advisors Private Equity, a Partner by Skyline Management LLC, a Principal by Venrock Associates, a Founder by KAI Pharmaceuticals, Inc., a Chief Executive & Financial Officer by E-Scape Bio, Inc., and a Board Director by Velia, Inc. He also served on the board at Crescendo Bioscience LLC, Eikon Therapeutics, Inc., Genocea Biosciences, Inc., Pionyr Immunotherapeutics, Inc. and Sutro Biopharma, Inc. He received his undergraduate degree from the University of California, Berkeley, an MBA from Stanford Graduate School of Business and a doctorate degree from Stanford University.

Leon Chen active positions

CompaniesPositionStart
Private Equity Investor 01/10/2019
Director/Board Member -

Former positions of Leon Chen

CompaniesPositionEnd
EIKON THERAPEUTICS, INC. Chief Executive Officer -
LOGICBIO THERAPEUTICS, INC. Director/Board Member 16/11/2022
NURIX THERAPEUTICS, INC. Director/Board Member 28/05/2021
Private Equity Investor 30/09/2019
Chief Executive Officer 23/08/2018
See the detail of Leon Chen's experience

Training of Leon Chen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services